STAAR SURGICAL CO (STAA)
Health Care / Health Care Equipment
S&P SmallCap 600$19.34
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 3 of 5 models — moderate confidence
Is STAAR SURGICAL CO a Good Investment in 2026?
STAAR SURGICAL CO (STAA) scores 1.3 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating STAAR SURGICAL CO as Caution. However, the Graham model rates it Caution. STAAR SURGICAL CO currently trades above its estimated fair value of $13, suggesting limited upside at current prices. STAAR SURGICAL CO ranks #1116 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value — the market may be pricing in future growth.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Caution
1/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is STAAR SURGICAL CO (STAA) a good investment?
What is STAAR SURGICAL CO's Piotroski F-Score?
Is STAA overvalued or undervalued?
How does STAA compare to other Health Care stocks?
What do investment models say about STAA?
Similar Stocks
Compare STAA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer